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Kelch-like ECH-associated protein 1 (Keap1) is a
ubiquitin E3 ligase specificity factor that targets
transcription factor nuclear factor (erythroid-derived
2)-like 2 (Nrf2) for ubiquitination and degradation.
Disrupting Keap1-Nrf2 interaction stabilizes Nrf2,
resulting in Nrf2 nuclear accumulation, binding to
antioxidant response elements (AREs), and tran-
scription of cytoprotective genes. Marburg virus
(MARV) is a zoonotic pathogen that likely uses bats
as reservoir hosts. We demonstrate that MARV
protein VP24 (mVP24) binds the Kelch domain of
either human or bat Keap1. This binding is of high
affinity and 1:1 stoichiometry and activates Nrf2.
Modeling based on the Zaire ebolavirus (EBOV)
VP24 (eVP24) structure identified in mVP24 an acidic
loop (K-loop) critical for Keap1 interaction. Transfer
of the K-loop to eVP24, which otherwise does not
bind Keap1, confers Keap1 binding and Nrf2 acti-
vation, and infection by MARV, but not EBOV, acti-
vates ARE gene expression. Therefore, MARV
targets Keap1 to activate Nrf2-induced cytoprotec-
tive responses during infection.
INTRODUCTION
Kelch-like ECH-associated protein 1 (Keap1) is a cellular adaptor
protein that links the Cul3/Rbx1 (Roc1) ubiquitin E3 ligase to the
oxidative stress response through its interaction with the tran-
scription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2)
(reviewed in Copple, 2012). Under homeostatic conditions,
Keap1 suppresses the cellular antioxidant transcriptional pro-
gram by directing the ubiquitin-mediated degradation of Nrf2
(Itoh et al., 1999; McMahon et al., 2003). Keap1 interacts, via
its Kelch domain, with two sites located in the Nrf2-ECH homol-Ceogy-2 (Neh2) domain of Nrf2 (Itoh et al., 1999; Tong et al., 2006).
Disruption of Nrf2-Keap1 interaction leads to transcription
of genes possessing antioxidant response elements (AREs)
(Tong et al., 2007). The upregulated ARE genes encode proteins
involved in detoxification reactions, cell survival, and immune
modulation (reviewed in Baird and Dinkova-Kostova, 2011; Ma,
2013).
ARE responses impact the outcome of viral infections. For
example, the Nrf2 pathway inhibits influenza virus and respira-
tory syncytial virus replication in cell culture and in vivo (Cho
et al., 2009; Kesic et al., 2011). In contrast, for hepatitis B virus,
hepatitis C virus, and human cytomegalovirus, induction of ARE
responsesmay protect infected cells from oxidative damage and
influence immune responses bymodulating immunoproteasome
function (Burdette et al., 2010; Ivanov et al., 2011; Lee et al.,
2013; Schaedler et al., 2010).
Marburg viruses (MARVs) and Ebola viruses (EBOVs),
members of the family Filoviridae, are emerging, zoonotic
pathogens that likely use bats as reservoir hosts. Filoviruses
are of concern because they cause hemorrhagic fever with a
high fatality rate in humans (reviewed in Brauburger et al.,
2012). Filoviruses encode multifunctional VP24 proteins, which
play important roles in the formation of viral nucleocapsids,
release of infectious virus particles, and modulation of viral
RNA synthesis (Bamberg et al., 2005; Beniac et al., 2012;
Bharat et al., 2011, 2012; Hoenen et al., 2006; Huang et al.,
2002; Mateo et al., 2011; Noda et al., 2006; Watanabe et al.,
2007; Wenigenrath et al., 2010). In addition, EBOV VP24
(eVP24) disrupts interferon (IFN) signaling pathways and
interacts with select karyopherin a proteins (KPNAs), thereby
blocking nuclear accumulation of tyrosine-phosphorylated
STAT1 (Mateo et al., 2010; Reid et al., 2006, 2007). In contrast,
MARV VP24 (mVP24) neither interacts with KPNAs nor inhibits
IFN signaling, and functionally relevant interactions with host
factors have not previously been defined (Valmas et al.,
2010). However, a recent mass spectrometry screen identified
Keap1 as a potential mVP24 binding partner (Pichlmair et al.,
2012).ll Reports 6, 1017–1025, March 27, 2014 ª2014 The Authors 1017
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Figure 1. mVP24 Interacts with Keap1 in CoIP Assays
(A) coIPs with HA antibody were performed on lysates of HEK293T cells cotransfected with plasmids for Flag-Keap1 and HA-mVP24 or HA-eVP24.Western blots
were performed for Flag and HA. WCL, whole cell lysate; IP, immunoprecipitation.
(B) Schematic diagram of Flag-tagged Keap1 domain deletion mutants used in (C).
(C) Flag-Keap1 domain deletion mutant constructs were coexpressed in HEK293T cells with HA-mVP24 and analyzed by coIP with Flag antibody.
(D) HA-mVP24 and either Flag-Keap1 or Flag-Keap1 R415A were analyzed by coIP as in (C).
(E) Overlay of the mVP24 structural model (orange) on the determined eVP24 structure (purple). The mVP24 K-loop (amino acids 205–212) is indicated in red.
(legend continued on next page)
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To date, the described mechanisms by which viruses engage
the ARE response do not involve direct interaction with compo-
nents of the signaling pathways. Rather, viruses are demon-
strated to activate other signaling pathways or induce oxidative
stress, indirectly activating antioxidant responses. Here, we
demonstrate that mVP24 but not eVP24 directly interacts
with the human and bat Keap1 proteins. We further define
the basis of the interaction and demonstrate that expression
of mVP24 but not eVP24 activates Nrf2, triggering cytopro-
tective responses. Correspondingly, MARV but not EBOV
infection activates ARE gene expression. Collectively, these
data suggest that MARV evolved to specifically target a
host cytoprotective gene expression program to facilitate its
replication.
RESULTS
mVP24 Interacts with Keap1
Coimmunoprecipitation (coIP) assays demonstrated that Flag-
tagged Keap1 interacts with HA-mVP24, but not with HA-
eVP24 (Figure 1A). Keap1 contains several previously defined
domains: the N-terminal region (NTR); the Bric-a-Brac, Tram-
track, Broad complex (BTB) domain; the intervening region
(IVR); and the Kelch domain/C-terminal region (CTR) (Komatsu
et al., 2010). Domain deletion mutants of Keap1 and a
construct comprising only the Kelch domain/CTR were tested
for mVP24 interaction by coIP (Figure 1B). The NTR and IVR
deletion mutants retained interaction, whereas deletion of
the Kelch/CTR resulted in loss of interaction (Figure 1C). The
isolated Kelch/CTR domain also interacted with mVP24 (Fig-
ure 1C). Therefore, the Kelch/CTR domain is necessary and
sufficient to interact with mVP24 (Figure 1C). The mutation to
alanine of Keap1 Kelch domain residue R415 disrupts interac-
tion with Nrf2 (Lo et al., 2006). Similarly, Keap1 R415A did not
coprecipitate with mVP24 (Figure 1D), suggesting that Nrf2
and mVP24 interact with the Keap1 Kelch region in a similar
fashion.
To gain insight into the region(s) of mVP24 required to interact
with Keap1, we used our recently solved structure of VP24 from
Zaire EBOV, which is very similar to the structures of Sudan and
Reston eVP24s (Zhang et al., 2012) (see Supplemental Experi-
mental Procedures, Supplemental Results, and Table S1), and
the Phyre2 software package to obtain a molecular model of
mVP24 (Kelley and Sternberg, 2009). The resulting structural
model identified a loop (the K-loop, amino acids 202–212) that
is likely solvent exposed (Figure 1E). The sequence near the
K-loop is not well conserved among filoviral VP24 proteins.
This loop contains a sequence DIEPCCGE that is reminiscent
of the high-affinity binding motif of DXXTGE, used by Nrf2 to
interact with the Keap1 Kelch domain (Lo et al., 2006). Among
the several Keap1 Kelch domain binding determinants, ‘‘GE’’
motifs appear to be the most highly conserved, with nearby
upstream acidic residues also playing an important role for(F) Flag-Keap1 and HA-mVP24 wild-type or mutants were analyzed by coIP as in
(G) Flag-Keap1 and HA-mVP24, eVP24, eVP24 DIEPCCGE, or eVP24 K-loop we
(H) Flag-mVP24 and HA-Keap1, bat-Keap1, and bat-Kelch were coexpressed in
See also Figure S1.
Ceseveral interacting partners (Komatsu et al., 2010; Padmanab-
han et al., 2008). Given this similarity, we made three HA-tagged
mVP24 constructs (Figure 1F). In ‘‘mVP24 linker,’’ the 205-
DIEPCCGE-212 sequence was replaced with a serine-glycine
linker. ‘‘mVP24 D205A/E207A’’ and ‘‘mVP24 G211A/E212A’’
were designed based on analogous loss-of-binding mutants
described for cellular Keap1-interactor p62 (Komatsu et al.,
2010). By coIP, wild-type mVP24 strongly interacted with
Keap1, mVP24 D205A/E207A interacted weakly, and no interac-
tion was detected with either mVP24 linker or mVP24 G211A/
E212A (Figure 1F). To assess the role of the DIEPCCGE motif
for interaction with Keap1, DIEPCCGE was swapped in place
of the corresponding residues within eVP24, creating ‘‘eVP24
DIEPCCGE.’’ We also replaced the loop of eVP24 (202-
QEPDKSAMDIRHPGPV-217) with the mVP24 K-loop (202-
RRIDIEPCCGETVLSESV-219), creating the ‘‘eVP24 K-loop.’’
eVP24 DIEPCCGE and eVP24 K-loop interacted with Keap1,
with the full K-loop appearing to confer better binding, whereas
wild-type eVP24 once again did not interact with Keap1
(Figure 1G). These results demonstrate that the DIEPCCGE
sequence and the K-loop, when placed in the context of the
VP24 structural scaffold, play a critical role for mVP24-Keap1
interaction.
MARVs likely use bats as reservoir hosts (Amman et al., 2012;
Towner et al., 2009). Therefore, a specific viral interaction with
Keap1 likely evolved and should be conserved in bats. Alignment
of human Keap1 and two divergent bat species, a microbat
(Myotis lucifugus) and a megabat (Pteropus alecto), revealed
97% amino acid identity between human and microbat Keap1
and 98% amino acid identity between human and megabat
Keap1 (data not shown). Full-length Keap1 (bat-Keap1) and
Kelch domain (bat-Kelch) constructs were generated from
an available microbat (Myotis velifer incautus) cell line. Both
coprecipitate with mVP24 with efficiencies similar to that of
human Keap1 (Figure 1H).
Keap1 inhibits ARE gene expression through its interaction
with Nrf2 (McMahon et al., 2003). When Keap1 repression is
relieved, which can be due to posttranslational modification of
Keap1 or interaction with select Kelch domain binding partners
such as p62, Nrf2 translocates to the nucleus and activates
ARE gene expression (Itoh et al., 1999; McMahon et al., 2003).
To determine whether the interaction of mVP24 with the Keap1
Kelch domain activates Nrf2, a GFP-Nrf2 fusion protein was
expressed alone or in the presence of Flag-Keap1 and HA-
tagged wild-type mVP24, mutant mVP24 or wild-type, or
chimeric eVP24s. Overexpression of Nrf2, which is known to
overwhelm the available endogenous Keap1, resulted in nuclear
localization of GFP-Nrf2, as expected (Figure S1). Coexpression
of Keap1 retained most of the Nrf2 in the cytoplasm. Additional
expression of mVP24 and eVP24-K-loop restored Nrf2-GFP
nuclear localization, whereas mVP24 mutants and eVP24-
DIEPCCGE, which do not interact efficiently with Keap1, did
not (Figure S1; see Supplemental Results for details).(A) and (C).
re coexpressed in HEK293T cells and analyzed by coIP as in (A).
HEK293T cells and analyzed by coIP as in (C).
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Figure 2. mVP24 Binds to Keap1 Kelch
Domain with High Affinity and Specificity
(A and B) Representative ITC data for Kelch
domain of Keap1 binding to (A) Nrf2 Neh2 domain
and (B) mVP24. Raw heats of reaction versus time
(top panels) and the integrated heats of reaction
versus molar ratio of ligand to receptor (bottom
panels) are shown. Thermodynamic binding pa-
rameters of KD = 170 ± 60 nM, DH =1.96 ± 0.13
104 kcal/mol, TDS = 10.4 kcal/mol, and n (no. of
sites) = 0.49 ± 0.02 for (A) and KD = 158 ± 20 nM,
DH = 2.10 ± 0.03 3 104 kcal/mol, TDS =
11.7 kcal/mol, and n (no. of sites) = 1.00 ± 0.01
for (B) were obtained.
(C) mVP24 binding to Kelch prevents Nrf2-Neh2
interaction. Coomassie blue-stained SDS-PAGE
of a pull-down assay where MBP-mVP24 was
immobilized on amylose resin (BB, bound beads)
is shown. Keap1 Kelch and Nrf2 Neh2 domain
were subsequently added to the resin (I, input),
and the resin was washed with buffer (washes).
The final bound bead sample (FB, final beads) is
indicated. M, molecular weight marker.
See also Figure S2.mVP24 Binds the Keap1 Kelch Domain with High Affinity
and Specificity
Binding of mVP24 to Keap1 Kelch was further evaluated
by isothermal titration calorimetry (ITC), which measures heat
generated by these exothermic interactions. ITC results
confirmed that Keap1 Kelch binds the Nrf2 Neh2 domain with
high affinity (KD = 170 ± 60 nM) and stoichiometry (n = 0.46)
(Figure 2A) and support a stoichiometry of 2:1 for Kelch binding
to Neh2 with thermodynamic parameters similar to those previ-
ously reported by Tong et al. (2006). Assays under similar condi-
tions for Kelch-mVP24 resulted in a KD of 158 ± 20 nM (Figure 2B)
with a binding stoichiometry of 1:1.
To gain additional mechanistic insight, we performed com-
petition pull-down experiments using wild-type mVP24, eVP24,
and eVP24 K-loop, which were designed based on the mVP24
structural model (Figures S2A–S2C). We established the basal
binding conditions for the Kelch and Neh2 interaction by pull-
down (Figure S2D) as well as Kelch binding to mVP24
(Figure S2E) and examined the ability of recombinant eVP24
(Figure S2F) and eVP24 K-loop (Figure S2G) to bind the Keap11020 Cell Reports 6, 1017–1025, March 27, 2014 ª2014 The AuthorsKelch domain. Next, we assessed
whether mVP24 can outcompete Neh2
binding to the Kelch domain. A complex
between the Kelch domain and Neh2
was preformed, and the ability of an
immobilized mVP24 protein to displace
Neh2 from the Kelch/Neh2 complex
was assessed. Despite similar affinities
of Neh2 and mVP24 for Kelch domain,
mVP24 can bind the Kelch domain in
the presence of a 2-fold excess of
Neh2 (Figure 2C). Therefore, in the
absence of other factors, mVP24 dis-
places Nrf2 from Keap1. This provides abiochemical explanation as to how the mVP24-Keap1 inter-
action triggers Nrf2 nuclear localization.
mVP24 Expression Activates ARE-Directed Gene
Expression
Stimuli that disrupt the Nrf2-Keap1 interaction and promote
Nrf2 nuclear localization activate expression of ARE genes (re-
viewed in Magesh et al., 2012). We therefore assessed the
ability of wild-type or mutant mVP24s to activate an ARE lucif-
erase reporter gene. Cellular Keap1-interacting protein p62, a
previously described activator of Nrf2, served as a positive
control (Komatsu et al., 2010; Lau et al., 2010). Expression of
mVP24 induced the ARE reporter to similar levels as p62 (Fig-
ure 3A). In contrast, mVP24 linker mutant and mVP24 G211A/
E212A did not activate the ARE promoter. mVP24 D205A/
E207A did activate the ARE promoter but to a lesser extent
than wild-type mVP24, reflecting the residual binding activity
of this mutant for Keap1 (Figure 3A). Therefore, Nrf2 activation
correlates with Keap1-mVP24 binding activity (Figure 1F). In a
separate experiment, expression of Nrf2 alone resulted in
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Figure 3. mVP24 Activates Expression of
ARE Genes
(A and B) HEK293T cells were transfected with the
ARE luciferase reporter plasmid, a constitutively
expressed Renilla luciferase plasmid, and
pCAGGS (empty vector) or increasing concentra-
tions of HA-p62, Flag-wild-type mVP24, or mVP24
mutants. (B) Same as (A), with the additional
overexpression of Flag-Nrf2 and Flag-Keap1. At
18 hr posttransfection (hpt), luciferase activity was
assayed for (A) and (B). Western blots performed
for HA and Flag are indicated.
(C) Same assay protocol as (A) but transfected
with HA-mVP24, eVP24, or eVP24 mutants.
(D) pCAGGS, Flag-Nrf2, mVP24, or mVP24
G211A/E212A was transfected in triplicate in
HEK293T cells. At 24 hpt, qRT-PCR was per-
formed to quantifymRNAs for the indicated genes,
normalized to the RPS11 mRNA.
(E) HEK293T cells were transfected with the indi-
cated plasmids, and 18 hpt, endogenous NQO1
was measured by western blot.
(F) Cell viability assay. HEK293T cells were trans-
fected with pCAGGS, Flag-Nrf2, mVP24, or
mVP24 G211A/E212A and 24 hpt were treated
with vehicle control (ethanol) or 5 mM menadione
(M) for 3 hr.
In (A)–(D), values represent the mean and SEM
of triplicate samples, and statistical significance
was assessed by a one-way ANOVA comparing
columns to the control (white bar): ***p < 0.001,
**p < 0.01, and *p < 0.05. Samples in (F) represent
the mean and SEM of six samples, and sig-
nificance was assessed by a one-way ANOVA:
*p < 0.05.
See also Figure S3.greater than 100-fold ARE reporter activation (Figure 3B).
Keap1 coexpression inhibited the activation. mVP24 expres-
sion relieved the repression of Nrf2, resulting in ARE gene
expression (Figure 3B). None of the mutant mVP24s induced
significant ARE activation, despite expression comparable to
that of wild-type mVP24 (Figure 3B). This suggests that the
residual binding of mVP24 D205A/E207A is not sufficient
to disrupt the repressive activity of the overexpressed Keap1
(Figure 3B). Although expression of eVP24 did not activate
the ARE reporter, expression of the mutant eVP24-DIEPCCGE
resulted in a slight increase in reporter activity, and eVP24
K-loop significantly induced ARE reporter expression (Fig-
ure 3C). Similarly, bat-Keap1 inhibited the activation of the
ARE reporter by overexpressed human Nrf2 (Figure S3A), and
mVP24 expression relieved the repression mediated by bat-
Keap1 on the ARE reporter (Figure S3A). Therefore, mVP24
interaction with Keap1 has functional consequences because
it can trigger Nrf2-dependent transcriptional activity in a
K-loop-dependent manner.Cell Reports 6, 1017–1025mVP24 expression also induced
expression of the endogenous ARE
genes, NAD(P)H quinone oxidoreduc-
tase 1 (NQO1) and glutamate-cysteine
ligase, modifier subunit (GCLM) (Lauet al., 2010), as assessed by quantitative RT-PCR (qRT-
PCR) (Figures 3D and S3B). Neither the mVP24 mutants
nor eVP24 induced expression of these genes (Figure S3).
In contrast, eVP24 DIEPCCGE and eVP24 K-loop did
induce significant levels of GCLM mRNA (Figures 3D and
S3B). Correspondingly, NQO1 protein levels increased in
the presence of wild-type but not mutated mVP24s, eVP24,
or the eVP24 chimeras (Figures 3E and S3C). Interestingly,
the eVP24 chimeras did not induce NQO1 and induced
GCLM mRNA to a lesser extent than did mVP24. This
may reflect in part an as yet uncharacterized inhibitory
activity of eVP24 on Nrf2-induced transcription responses
that can be seen in ARE reporter gene assays (Figure S3D).
Consistent with the ARE induction, cells transfected with
Nrf2 (a positive control) or mVP24 were protected from
killing by menadione, a compound that induces oxidative
damage. In contrast, significant cell death was detected in
the pCAGGS and mVP24 G211A/E212A-transfected cells
(Figure 3F)., March 27, 2014 ª2014 The Authors 1021
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Figure 4. MARV Infection Upregulates the
Nrf2 Antioxidant Pathway
(A and B) THP-1 cells were infected with MARV-
Ang or Zaire EBOV (moi = 3) and subjected
to expression analysis by mRNA sequencing
(mRNA-seq).
(A) Heatmap displaying the expression profile of 30
Nrf2-activated genes (Chorley et al., 2012). Red
indicates upregulated genes (maximum induction,
8.55-fold relative to mock-infected cells). Green
indicates downregulated genes (lowest value, 0.2-
fold relative to mock-infected cells). Gray indicates
genes undetected in the mRNA-seq.
(B) mVP24 and eVP24 mRNA expression levels
represented as median nucleotide coverage.
(C) THP-1 cells were infected with MARV-Ang or
MARV-Mus (moi, 1) and subjected to qRT-PCR.
Values were normalized to RPS11. Mock sample
contains a single replicate; MARV-Ang and MARV-
Mus represent the mean and SEM of triplicate
samples.
See also Figure S4.MARV Infection Induces the Expression of
Nrf2-Responsive Genes
mVP24 activates Nrf2 via interaction with Keap1, but eVP24
does not, suggesting that MARV but not EBOV infection should
induce an ARE response. To test this hypothesis, we profiled the
expression of select ARE genes in THP-1 cells following MARV
Angola strain (MARV-Ang) or Zaire EBOV infection (multiplicity
of infection [moi], 3). A substantial number of ARE genes were
upregulated in MARV-infected THP-1 cells as the infection pro-
gressed and mVP24 mRNA levels increased (Figures 4A and
4B). Although a fewARE geneswere upregulated by EBOV infec-
tion, the response was not as global as was seen with MARV,
and the response did not correlate well with eVP24 expression
(Figures 4A and 4B). The mVP24 K-loop sequence is conserved
among MARV strains, suggesting that ARE activation should
also be shared between MARV strains. Indeed, induction of
two representative ARE genes, heme oxygenase 1 (HO-1) and
GCLM, was demonstrated by qRT-PCR following infection of
THP-1 cells withMARV-Ang orMusoke (MARV-Mus) (Figure 4C).
Interestingly, HO-1 is highly upregulated during MARV infection
(Figure 4A), and a recent study has indicated that EBOV replica-
tion/transcription is inhibited by HO-1 expression (Hill-Batorski
et al., 2013). However, using a MARV minigenome assay, we
did not detect any inhibition following HO-1 overexpression (Fig-
ure S4; see Supplemental Results for further details), suggesting
that upregulation of this ARE may not impair MARV replication.
DISCUSSION
The host antioxidant response has been increasingly recognized
as relevant to virus infections. Here, we demonstrate a direct,1022 Cell Reports 6, 1017–1025, March 27, 2014 ª2014 The Authorshigh-affinity interaction between mVP24
and the Kelch domain of the human and
bat Keap1, a major negative regulator of
antioxidant responses (see also Supple-
mental Discussion on bat Keap1). Thisinteraction, for which we define a critical role for the mVP24
K-loop sequence, can disrupt Nrf2-Keap1 interaction and induce
a cytoprotective state through transcriptional activation of the
ARE promoter. Although other viruses have previously been
demonstrated to activate antioxidant responses, the mecha-
nisms of activation appear indirect, with virus infection triggering
oxidative stress or other cellular signaling pathways that stimu-
late Nrf2 nuclear accumulation (Burdette et al., 2010; Cho
et al., 2009; Ivanov et al., 2011; Kesic et al., 2011; Lee et al.,
2013; Schaedler et al., 2010). In contrast, the direct interaction
between mVP24 and Keap1 provides compelling evidence
that viruses have evolved mechanisms to engage the cellular
antioxidant response as part of their replication strategy.
Keap1-Nrf2 interaction is required for negative regulation of
the antioxidant response. A number of stimuli, such as oxidative
stress, that perturb the Keap1-Nrf2 interaction stabilize Nrf2,
allowing it to accumulate in the nucleus where it binds AREs
and cooperates with other factors to activate ARE-containing
promoters (Dinkova-Kostova et al., 2002; Zhang and Hannink,
2003). In addition, the interaction of the Keap1 Kelch domain
with p62, an autophagy factor that functions in the clearance
of polyubiquitinated complexes, activates Nrf2 through the
disruption of binding via the lower-affinity Keap1 binding site
onNrf2 (Komatsu et al., 2010; Lau et al., 2010).We demonstrated
that the mVP24-Keap1 interaction requires the Keap1 Kelch
domain, as is true for many other Keap1 interactors (Kim et al.,
2010; Komatsu et al., 2010; Lo and Hannink, 2006; Niture and
Jaiswal, 2011). Our data further suggest that the interaction of
mVP24 with Keap1 can disrupt the high-affinity Nrf2-Keap1
binding site, leading to the subsequent nuclear localization of
Nrf2 and activation of the antioxidant response.
The structural basis for the Keap1 Kelch interaction with pep-
tides derived from several cellular Keap1 binding partners,
including Nrf2, p62, and prothymosin a, was previously
described by Komatsu et al. (2010), Lo et al. (2006), and Padma-
nabhan et al. (2008). These peptides bind the bottom of the
Keap1 b sheet propeller, which forms a basic pocket, in part
through electrostatic interactions with Keap1 arginine residues.
Common features of the binding peptides include acidic resi-
dues along with a GE motif (Komatsu et al., 2010; Lo and Han-
nink, 2006). Data obtained with mutated mVP24 K-loop acidic
residues and the GE motif support a similar mode of binding
for mVP24, although we cannot exclude a contribution of other
parts of mVP24. Consistent with a model where the mVP24
loop and the acidic residues within the loop make analogous
contacts with the Keap1 Kelch domain, substitution of Keap1
R415 to alanine abrogated Keap1-mVP24 interaction.
It is striking that MARVs and EBOVs differ in their interaction
with the ARE response (see Supplemental Discussion for de-
tails). Although there are no structures of mVP24, several struc-
tures of eVP24s, including Sudan andReston EBOVs (sVP24 and
rVP24) (Zhang et al., 2012) as well as Zaire EBOV (eVP24), are
available (Figure 2; PDB 4M0Q). In order to evaluate the
mVP24 structure, we used the eVP24 structure, which was
most complete as the basis for the Phyre2-threading model
of mVP24. In the mVP24 model, the K-loop contains the
DIEPCCGE sequence, a sequence that is not conserved be-
tween mVP24 and eVP24 but shows similarity to motifs of other
Keap1-interacting ‘‘GE motifs.’’ Replacement of the K-loop res-
idues with a heterologous linker sequence or mutation to alanine
of the D205 and E207 or of G211 and E212 was sufficient to
greatly reduce or abrogate binding, although it should be
acknowledged that the nuclear localization confounds interpre-
tation of the G211A/E212A mutant data. That the DIEPCCGE
loop is central to binding is confirmed by the fact that transfer
of the loop to eVP24, which otherwise does not interact with
Keap1, confers binding activity. Furthermore, wild-type mVP24
effectively competes with Nrf2 for binding to Keap1 in vitro and
dissociates GFP-Nrf2 from Flag-Keap1 in a K-loop-dependent
manner. These observations suggest a mechanism by which
mVP24 activates an ARE transcriptional response. Interestingly,
the mVP24 DIEPCCGE sequence diverges from other Keap1
binding motifs, such as the so-called ETGE motif of Nrf2
(DEETGE), with ‘‘PCC’’ inserted between ‘‘GE’’ and more
amino-terminal acidic residues. The presence of the Cys resi-
dues is intriguing given that Keap1-Nrf2 interactions are regu-
lated by oxidation. Whether these residues, which are not
present in other Keap1-interacting motifs, play an important
role in the mVP24-Keap1 interaction will be the subject of future
studies.
In addition to the ARE response, Keap1 regulates other stress-
induced cell survival pathways through interaction of its Kelch
domain with a variety of proteins, including PGAM5, IKKb, and
p62 (Kim et al., 2010; Komatsu et al., 2010; Lau et al., 2010;
Lee et al., 2009; Lo and Hannink, 2006; Niture and Jaiswal,
2011). mVP24 disruption of these Keap1 interactions could
inhibit apoptosis, activate NF-kB-mediated cell survival path-
ways, and influence autophagy (Fan et al., 2010; Kim et al.,
2010; Lee et al., 2009; Niture and Jaiswal, 2011). Furthermore,Cethe stable interaction of mVP24 and Keap1, which did not de-
tectably influence mVP24 expression levels, might allow the
recruitment of Keap1 and binding partners for new functions.
Further study is therefore required to fully elucidate the impact
of the mVP24-Keap1 interaction upon MARV infection.
EXPERIMENTAL PROCEDURES
CoIP
Twenty-four hours posttransfection with the indicated plasmids, HEK293T
cells were lysed in NP-40 lysis buffer (50 mM Tris [pH 7.5], 280 mM NaCl,
0.5% Nonidet P-40, 0.2 mM EDTA, 2 mM EGTA, 10% glycerol, and protease
inhibitor [cOmplete; Roche]). Anti-FLAGM2 magnetic beads or anti-HA beads
(Sigma-Aldrich) were incubated with lysates for 1 hr at 4C, washed five times
in NP-40 lysis buffer, and eluted using either 33 FLAG peptide (Sigma-Aldrich)
or by boiling in sample loading buffer.
Activation of Nrf2
For ARE reporter gene assays, a commercially available reporter gene,
pGL4.37[luc2P/ARE/Hygro] (ARE) (Promega), was cotransfectedwith a consti-
tutively expressed Renilla luciferase reporter plasmid (pRL-tk; Promega), and
the indicated protein expression plasmids. At 18 hr posttransfection, a dual
luciferase reporter assay (Promega) was performed in triplicate, and firefly
luciferase valueswere normalized toRenilla luciferase values. Statistical signif-
icance was assessed with one-way ANOVA using Tukey’s test for compari-
sons to the control. Protein expression levels were assessed by western
blot. Levels of endogenous NQO1, GCLM, or HO-1 mRNAs were assessed
by qRT-PCR, and NQO1 protein levels were assessed by western blot using
a commercially available antibody (Santa Cruz Biotechnology).
Virus Infections
The following infections were performed under BSL-4 conditions at the
Galveston National Laboratory. THP-1 cells were differentiated overnight
with 100 nM PMA and infected with MARV-Ang (moi = 3 or 1), MARV-Mus
(moi = 1), or EBOV (moi = 3). Viral total RNA was extracted with TRIzol at the
indicated time points for analysis by deep sequencing or qRT-PCR. For
deep sequencing, mRNA was purified with Oligo(dT) magnetic beads (Invitro-
gen). cDNA libraries were generated (NEBNext; New England Biolabs) and
sequenced on the Illumina HiSeq 2500 platform, and relative expression for
each gene of interest was determined. For qRT-PCR, cDNA was generated
with Oligo(dT) primers, and relative expression for each gene of interest was
determined by normalizing to the indicated housekeeping gene. Refer to Sup-
plemental Experimental Procedures for additional details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Discussion, Supplemental Experimental Procedures, four figures, and one
table and can be found with this article online at http://dx.doi.org/10.1016/j.
celrep.2014.01.043.
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